Advancing secondary structure characterization of monoclonal antibodies using Microfluidic Modulation Spectroscopy.

Anal Biochem

Amgen Inc., Higher Order Structure, Attribute Sciences, Thousand Oaks, CA, 91320, United States. Electronic address:

Published: June 2022

Infrared (IR) spectroscopy is rapidly gaining traction for monitoring biotherapeutic critical quality attributes. Microfluidic Modulation Spectroscopy (MMS), a novel automated IR technology, has been shown to be an effective technique for generating high quality, reproducible secondary structure data for protein therapeutics including monoclonal antibodies. In this study, monoclonal antibodies (mAbs) at concentrations ranging from 0.5 to 50 mg/mL were analyzed and high-quality data was obtained by optimizing two critical acquisition parameters (a) sample modulation frequency and (b) detector dwell time settings. The ability to generate reproducible data with high sensitivity at low formulation concentrations indicates that MMS is a reliable method for evaluating the secondary structure of low concentration biotherapeutic formulations and modalities.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ab.2022.114629DOI Listing

Publication Analysis

Top Keywords

secondary structure
12
monoclonal antibodies
12
microfluidic modulation
8
modulation spectroscopy
8
advancing secondary
4
structure characterization
4
characterization monoclonal
4
antibodies microfluidic
4
spectroscopy infrared
4
infrared spectroscopy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!